We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA ‘Adaptive Licensing’ Pilot Could Speed Access to New Drugs
EMA ‘Adaptive Licensing’ Pilot Could Speed Access to New Drugs
The European Medicines Agency last month launched a pilot program to speed new therapies to patients by authorizing products in stages for targeted populations.